Fantastic Voyage
In 1966, movie-goers were treated to the release of a film called Fantastic Voyage, a Cold War science fiction thriller about a scientist who is nearly killed in an assassination attempt.
As he hovers between...
Market place becoming more competitive
Popular as this technology is, there are others vying for a niche in the same markets with equal claims on convenience and popularity with patients and clinicians alike.
In 2011/12 Garcia-Diaz et al studied patient...
Think you know Harrogate? Think again!
Harrogate and district has a long established reputation as a tourist destination. Mention of Harrogate brings up images of Bettys famous tearooms; of the Tour de Yorkshire; the beautiful parks and gardens.
Spreading out from...
Depression up, Covid-19 down in disease study list
Depression is now one of the top five most studied disease areas in clinical development, according to new global analysis by Phesi.
The mid-year analysis of all this year’s trials to date reveals that Covid-19...
The future of healthcare: enabling a culture of prevention though tech
Our existing healthcare systems are in need of an overdue shift in focus, says Simon Pavitt, Chief Operating Officer, London Technology Club. While the compassion, energy and dedication of healthcare workers should never be...
Research at the interface of technology and life sciences
Professor Jens Jordan, Director of the Institute of Aerospace Medicine
The Institute of Aerospace Medicine at the German Aerospace Center (DLR) comprises departments in Cologne and in Hamburg with internationally unique research infrastructure. At DLR, the...
Sizzling breakthrough for 3D meat
A 4oz steak has been ‘lab-grown’ using a digital design file.
Israeli firm MeaTech 3D Ltd. cultivated the bio-printed steak using real fat and muscle cells. The cells were produced using an advanced process that...
Major steps being taken in battle against arthritis
Researchers from many disciplines are working together to ease the pain of rheumatoid arthritis patients and potentially save the NHS millions of pounds on ineffective drugs.
Doctors can waste a long time prescribing different therapies...
Regulation that governs the biosimilar industry
One of the major hurdles for biosimilars manufacturers is meeting the rigorous demands of regulators who are coming to terms with the challenges that the new industry provides.
In the European Union, for example, a...
Priority response plan (prp) for bio-decontamination of a biopharmaceutical production facility
Multinational Biopharmaceutical Company, Singapore - case study
EXECUTIVE SUMMARY
A multinational biopharmaceutical company in Asia, was looking to introduce a rigorous plan to ensure high-level bio-decontamination of their manufacturing facility in the event of contamination.
The customer...
Call to address lack of patient diversity in research
By Kate Shaw, CEO of Innovative Trials.
Innovative Trials, a clinical trial patient recruitment company, is calling on the medical research community and pharmaceutical sector to come together to tackle the issue of patient diversity in...
Can compliance in pharmaceutical logistics by air be reached through industry collaboration?
Pharmaceuticals makeup 1.9% of all air cargo and generate revenues of $1.4 billion per year - 2.6% of total air cargo. In the next three years (2018-2020), growth in pharmaceuticals being transported by air is...
Remarkable breakthroughs that herald the age of bionics
He was one of the television hits of the 1970s, the Six Million Dollar Man with his super-enhanced vision and reconstructed bionic limbs that allowed him to run at incredible speeds and jump huge...
Targeting the right treatment at the right patient
One of the rapidly growing concerns in medicine is the anxiety that a lot of drugs do not work for a large number of the patients for whom they are prescribed.
By Frances Griss
Finding the...
Cell therapy manufacturing industry takes big steps forward
Cell Therapy production across the world has made some significant advances in recent months, with investment in manufacture announced and exciting research suggesting new applications.
The industry in the UK has taken a step forward...
Robust, ready-to-use cell-based potency assays for biosimilar development
By Jane Lamerdin, Ph.D., Abhishek Saharia, Ph. D.
DiscoveRx Corporation, Fremont, CA 94538, USA
Biosimilars are defined as drugs that are “highly similar” to or “interchangeable” with an approved biologic. The lack of a clearly defined...